A synthetic glycosaminoglycan mimetic (RGTA) modifies natural glycosaminoglycan species during myogenesis. by Barbosa, I. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/48801
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Introduction
The basal lamina surrounding muscle fibres fulfils many
developmental and physiological roles (Sanes, 2003; Sanes et
al., 1990; Sanes et al., 1986). The basal lamina networks are
interconnected with resident and cell surface proteins and
proteoglycans (PG). These PGs consist of a core protein to
which glycosaminoglycan (GAG) moieties are covalently
linked. Heparan sulfate proteoglycans (HSPG) constitute the
major portion of proteoglycans of the basal lamina of skeletal
muscle cell surfaces (Brandan et al., 1996; Brandan et al.,
1991; Cornelison et al., 2001; Larrain et al., 1997). Highly
regulated spatiotemporal distribution of basal lamina
components and of cell surface HSPGs such as collagen, agrin,
perlecan, glypicans or syndecans (Sanes et al., 1990) create a
specific microenvironment around muscle cells that act as a
determinant for the events of myogenesis in particular by
regulating bioavailability of growth factors (Larrain et al.,
1997; Larrain et al., 1998). A growing body of evidence
indicates that most growth factors involved in the control of
cellular growth and differentiation can be stored in the
extracellular matrix through specific interaction with GAGs,
especially heparan sulfate (HS). Heparin or HS stabilizes and
protects growth factors from degradation (Sommer and Rifkin,
1989) and may even potentiate their activity (Lyon and
Gallagher, 1998; Rahmoune et al., 1998; Rapraeger, 2002).
From these binding sites, the growth factors traditionally
designated as heparin binding growth factors (HBGF), can be
released and accomplish cellular activating functions.
The control of bioavailability of HBGF may in part be
mediated by an affinity of these factors for specific sequences
of the sugar moiety of proteoheparan sulfates. In particular, the
pattern of sulfation regulates the affinity of growth factors to
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Crucial events in myogenesis rely on the highly regulated
spatiotemporal distribution of cell surface heparan sulfate
proteoglycans to which are associated growth factors, thus
creating a specific microenvironment around muscle cells.
Most growth factors involved in control of myoblast growth
and differentiation are stored in the extracellular
matrix through interaction with specific sequences of
glycosaminoglycan oligosaccharides, mainly heparan
sulfate (HS). Different HS subspecies revealed by specific
antibodies, have been shown to provide spatiotemporal
regulation during muscle development. We have previously
shown that glycosaminoglycan (GAG) mimetics called
RGTA (ReGeneraTing Agent), stimulate muscle precursor
cell growth and differentiation. These data suggest an
important role of GAGs during myogenesis; however, little
is yet known about the different species of GAGs
synthesized during myogenesis and their metabolic
regulation. We therefore quantified GAGs during
myogenesis of C2.7 cells and show that the composition of
GAG species was modified during myogenic differentiation.
In particular, HS levels were increased during this process.
In addition, the GAG mimetic RGTA, which stimulated
both growth and differentiation of C2.7 cells, increased the
total amount of GAG produced by these cells without
significantly altering their rate of sulfation. RGTA
treatment further enhanced HS levels and changed its sub-
species composition. Although mRNA levels of the enzymes
involved in HS biosynthesis were almost unchanged during
myogenic differentiation, heparanase mRNA levels
decreased. RGTA did not markedly alter these levels. Here
we show that the effects of RGTA on myoblast growth and
differentiation are in part mediated through an alteration
of GAG species and provide an important insight into the
role of these molecules in normal or pathologic myogenic
processes.
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HS (Fernig et al., 2000; Ford-Perriss et al., 2002; Kreuger et
al., 1999; Kreuger et al., 2001). Interestingly, it has been
demonstrated, using phage display antibodies, that HSs form a
family of molecules that present a spatiotemporal regulation in
differentiating skeletal muscle cells, thus suggesting a subtle
regulating role of these molecules (Dennissen et al., 2002;
Jenniskens et al., 2000; Jenniskens et al., 2002). Indeed, several
growth factor binding oligosaccharides sequences have been
established (Allen et al., 2001; Kreuger et al., 2001; Olwin and
Rapraeger, 1992; Turnbull et al., 1992). They govern the
activity of growth factors on cells, as has been shown for
instance for fibroblast growth factor 2 (FGF2) (Berry et al.,
2003; Rapraeger et al., 1991).
We have used substituted dextran polymers that mimic
GAGs on the basis of their ability to interact with and to protect
several HBGFs against proteolysis (Meddahi et al., 1995;
Meddahi et al., 1996). These GAG mimetics were shown to
enhance tissue repair in various in vivo models including skin
(Meddahi et al., 1996), bone (Blanquaert et al., 1995) or colon
(Meddahi et al., 2002). They highly stimulate and improve
regeneration of denervated and crushed skeletal muscles
(Aamiri et al., 1995; Gautron et al., 1995; Zimowska et al.,
2001) as well as prevent most of the damage resulting from
acute skeletal or cardiac muscle ischemia (Desgranges et al.,
1999; Zakine et al., 2003). Therefore, these dextran polymers
were called RGTA (for ReGeneraTing Agent). Experiments
performed with satellite cells (also called muscle precursor
cells) in primary cultures have shown that these GAG mimetics
stimulate satellite cell growth and differentiation (Papy-Garcia
et al., 2002; Stockholm et al., 1999).
Taken together, these results suggest that the GAG moiety
of certain proteoglycans might regulate the differentiation
process of myoblasts into myotubes. However, little is known
about the GAG composition of myoblasts and myotubes.
Chondroitin sulfate (CS) and HS synthesis are greatly
increased in mdx satellite cells compared to normal muscle
satellite cells (Alvarez et al., 2002; Crisona et al., 1998). The
reduction of GAG sulfation by chlorate treatment of C2
myoblasts reduces their growth (Papy-Garcia et al., 2002) and
differentiation capacities (Melo et al., 1996).
These results prompted us to study changes in GAG levels
during myoblast differentiation in vitro and to identify their
species, using the C2.7 cell line. We also investigated whether
a specific RGTA, named RGD120 and structurally related to
heparin, would alter the content of the GAG species balance in
relation to its effect on myoblast growth and differentiation.
Materials and Methods
Materials
The RGTA used in this study, RGD120, was obtained from OTR3
(Sarl, Créteil, France). This molecule is a synthetic derivative of T40
dextran in which some of the hydroxyl groups were substituted by
carboxymethyl and sulfate groups (Fig. 1). The global degree of
substitution (d.s.) of each polymer was determined by acid-base
titration of the carboxylic and sulfate groups and by microanalysis of
the sulfur content; the fine structure was determined by 1H NMR
spectroscopy and HPLC gel filtration-light diffusion detection
(Ledoux et al., 2003). Full data were provided with the compound.
Myoblasts were supplied by Pinset and Montaras (Pinset et al.,
1988). Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine
serum (FBS), horse serum and 10× phosphate buffered saline (PBS)
were from Gibco-BRL-Life Technologie, (Cergy-Pontoise, France).
Sodium acetate, sodium formiate, formic acid, anthranilic acid and
proteinase K were from Merck (Darmstadt, Germany); propan-1-ol
was from Prolabo-VWR (Strasbourg, France). Ultrafree-MC Amicon
filters were from Millipore (Bedford, Massachusetts). Gelatin,
paraformaldehyde, p-nitrocatechol sulfate and all other chemicals
were from Sigma-Aldrich (St Louis, MO). Mowiol was from
Calbiochem (La Jolla, California). The protein assay kit was from
Bio-Rad Laboratories (California, USA). Epitope-specific antibodies
against HS were produced by the phage display technique (Jenniskens
et al., 2002). Anti c-myc tag rabbit polyclonal IgG (A-14) was from
Sigma, Alexa 488-conjugated goat anti-rabbit IgG was from
Molecular Probes (Eugene, USA). Electrophoresis material and
products were from Bio-Rad. Spectroscopic data were collected using
a scanning spectrophotometer PU 8740 UV/Vis (Phillips, Paris,
France). HPLC analysis was performed with a TSKgel G3000 PWXL
7.8 mm ID × 30 cm column from Tosohaas (Cambridge, UK) using
an LC240 fluorescence detector from Perkin Elmer (Division
Instruments, St Quentin, France); the HPLC pump was from Kontron
Instruments (Germany). Analysis of HPLC peaks was performed with
RadioStar software. Confocal microscopy images were acquired with
a Zeiss LSM 410 laser-scanning confocal Axiovert 135M inverted
microscope.
Cell cultures
The C2.7 cell line (Pinset el al., 1988) was maintained as sub-
confluent monolayers in DMEM containing 1 g/l glucose and 4 mM
L-glutamine supplemented with 20% FBS, 100 U/ml penicillin and
10 µg/ml streptomycin. Cells cultures were incubated at 37°C in 12%
CO2. Samples of proliferating cells (myoblasts) were taken during the
following 5 days after plating. To induce differentiation, the medium
was changed at sub-confluence (days 3 or 4 after plating) to DMEM
supplemented with 0.25% FBS and 0.25% horse serum. Samples of
differentiated cells were taken at the indicated times during the 48
hours following medium shift.
Evaluation of myoblast proliferation or differentiation
At the indicated times, cultures were trypsinized and cells were
Journal of Cell Science 118 (1)
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Fig. 1. Schematic structure of RGTA D120. The dextran derivative
on the 1-6 glucose polymeric chain contains carboxymethyl
(–CH2COO–) and sulfate residues (–SO3–) at degrees of substitution
of 0.26 and 1.92, respectively. Three differently substituted
glucosidic units are represented according to the nature of the group
linked to the C2 position. For easier interpretation, these units were
arranged in an arbitrary combination. R represents the possible
substituted groups in the global C3 and C4 positions. The position of
each group on the C-2 compared to C-3 + C-4 was also determined
by analyzing the anomeric proton signal by 1H NMR (300 MHz).
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counted in a Coulter Counter. In other cases, culture growth was
determined by DNA content evaluation using a diaminophenyl indole
(DAPI) assay (Brunk et al., 1979). In order to evaluate differentiation,
total activity and isoform ratio of creatine kinases (CK) on cellular
extracts were determined by a micro method using Biotrol reagents.
Samples containing equivalent amounts of CK activity in 1 µl were
loaded onto 1% agarose gels; isoforms were separated by
electrophoresis and revealed by using the CK reagent (Lagord et al.,
1993). Gels were illuminated with UV (365 nm) and images of the
fluorescent CK bands were analyzed by the Gene Tool Syngene
software. The percentages of B and M subunits were determined from
these images.
Preparation of GAG extracts
At the indicated times, cellular extracts and conditioned medium were
selected and treated as described previously (Barbosa et al., 2003). In
brief, cellular layer extracts were performed by scraping the cells in
K2HPO4 (50 mM, pH 8.0). Cellular extract was then digested in a
solution of 50 µg/ml proteinase K in 100 mM phosphate buffer pH
8.0 at 56°C overnight. Proteinase K was then inactivated by heating
the preparation for 10 minutes at 90°C. At this step, the amount of
DNA in aliquot samples was determined by 4,6-diamino-2-
phenylindole (DAPI) assay using salmon sperm DNA as a standard
(Brunk et al., 1979). Digested tissue was then filtered through an
Ultrafree-MC filter in order to eliminate interfering DNA and tissue
debris from the extract. This preparation was used for sulfated GAG
quantification. Conditioned medium from each plate was lyophilized
and dry powder was dissolved in 100 mM phosphate buffer and treated
with proteinase K as described above.
Quantification of GAG
Total sulfated GAG and HS or CS was quantified using a method
based on dimethylmethylene blue (DMMB) co-precipitation with
GAG (Barbosa et al., 2003). To take account of the presence of
synthetic sulfated GAGs (RGTA) in extracts, the value corresponding
to the added RGTA in cultures was subtracted from the total GAG
measurement. HS was quantified after nitrous acid treatment of total
GAG preparation, as it is known that this treatment selectively
eliminates HS (Bosworth and Scott, 1994). The GAG remaining in
the sample represented O-sulfated GAGs including CS. The N-
sulfated GAG (HS) content was then calculated as the difference
between the total GAGs and the O-sulfated GAGs in each sample.
Preparation of GAG labelled with anthranilic acid and HPLC
analysis
In order to enhance sensitivity of GAG detection using HPLC, we
prepared GAG samples that were tagged with anthranilic acid by
reductive amination of the proteinase K-digested samples. 100 µl of
proteinase K-treated GAG samples were incubated for 24 hours at
37°C under slow agitation with 200 µl of a 1:1 mixture containing 1
M anthranilic acid in ethanol and 1 M sodium cyanoborohydride
(NaCNBH3) prepared extemporaneously in 100 mM ammonium
acetate. The reaction was stopped by addition of 300 µl of 300 mM
acetate buffer at pH 4 and filtered through Ultra-free MC filters.
20 µl of the filtrate were injected in the HPLC system (TSK
G3000SWXL column). GAGs were eluted at 1.0 M NaCl at 1 ml/
minute and detected with an LC240 fluorescence detector. Total
GAG amounts, analyzed with the Radiostar software (Berthold,
Germany), represented the sum of the areas under each peak that
eluted between 6 and 18 minutes. As controls, samples that were not
treated with proteinase K and proteinase K alone were analyzed,
applying the same procedure. In such control samples, a very weak
background signal was detected in the HPLC system with respect to
digested samples.
Arylsulfatase assay
Determination of arylsulfatase A and B was adapted from a published
method (Baum et al., 1959). In brief, cells were homogenized in 250
mM sodium acetate buffer, pH 6.0 containing 0.5% Triton X-100. The
samples were kept on ice for 1 hour and centrifuged at 10,000 g for
10 minutes. Supernatants were then dialyzed for 18 hours against
distilled water. Proteins were measured using BCA reagent (Bio-Rad).
Arylsulfatase A was determined by colorimetry as followed: 50 µg
protein from cellular extracts in water were diluted to a final volume
of 50 µl in buffer A (10 mM sodium pyrophosphate, 1.7 M NaCl, 0.5
M sodium acetate, pH 5.0) and 50 µl nitrocatechol sulfate (10 mM)
diluted in buffer A was added. The reaction was allowed to occur for
60 minutes at 37°C and stopped by addition of 50 µl of 1.0 M sodium
hydroxide. The liberated nitrocatechol was measured at 540 nm. As
a standard, 4-nitrocatechol was used between 0.250 and 5 nmol in the
same buffer conditions. Aryl sulfate B was measured in similar
conditions but in buffer B (0.5 M sodium acetate, 10 mM barium
acetate, pH 6.0). 50 µl nitrocatechol sulfate (50 mM) in buffer B was
added to the protein extract. A standard curve with 4-nitrocatechol
was produced between 12.5 and 125 nmol. Two sets of assays were
prepared in order to perform incubation between 30 and 90 minutes.
The liberated 4-nitrocatechol was measured as described above. The
evaluation of arylsulfatase B under these conditions was performed as
described (Aqrabawi et al., 1993).
Real-time PCR analysis of enzymes involved in GAG
metabolism
The transcription levels of most of the enzymes involved in HS
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Fig. 2. Effect of RGTA on C2.7 cell growth. (A) Effect of different
concentrations of RGTA (0.1 to 20 µg/ml) on cell proliferation. Cells
were counted at day 4 and each value is the mean±s.d. of four
cultures. (B) Growth of C2.7 myoblasts in the presence of heparin
(10 µg/ml) or RGTA (0.5 µg/ml). DNA was measured in cellular
extracts at the indicated times. Each point is the mean±s.d. of three
determinations on three independent cultures.
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synthesis, namely exostosin (EXT) 1 and 2, N-deacetylase N-
sulfotransferase (NDST1), epimerase, 2-O-sulfotransferase (OST)
and 6OST1, as well as heparanase involved in HS degradation, have
been analyzed. Real-time PCR analyses were performed on RNA
extracted from differentiating C2.7 cells at the indicated time using
RNA treatment with Instapure Plus (Eurogentec, Seraingn, Belgium).
The use Instapure plus permitted elimination of any interference on
the RT and PCR steps which otherwise would occur owing to the
presence of polyanionic molecules such as RGTA. Such a drawback
has been already described for heparin (Bai et al., 2000).
The RNA pellet was dissolved in RNase-free water,
treated with DNA-free (Ambion Europe, UK) and its purity
verified on agarose gel. The reverse transcription reaction
was performed on 1 µg total RNA from cells by using the
oligo dT primer and the Superscript IITM preamplification
system (Invitrogen). Gene expression was quantified by real-
time PCR using the LightCycler Fast Start DNA Master
(Roche) with 0.2 µl cDNA, corresponding to 100 ng total
RNA in a 20 µl final volume, 3 mM magnesium chloride
and 0.5 µM of each primer (final concentration). Briefly,
quantitative PCR was performed for 45 cycles at 95°C for
15 seconds, at the specific annealing temperature for 25
seconds and 72°C for 30 seconds. Amplification specificity
was checked using a melting curve following the
manufacturer’s instructions. Some of the specific gene
primers of each enzyme of interest for real-time PCR
analysis were designed using Primers3 software based on
published sequences (Table 1). Heparanase, NDST1, 2OST
and 6OST1, and epimerase were used as described (Miao et
al., 2002; Ford-Perriss et al., 2002; Li et al., 2002). Results
were analyzed with LightCycler software v3.5 (Roche)
using the second derivative maximum method to set the
threshold cycle (CT). The quantitative analysis was carried
out using standard curves and normalized using the GeNorm
software and methodology (Vandesompele et al., 2002).
Four different reference genes [glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), RNA Polymerase II (RPII),
TATA-box binding protein (TBP) and α-tubulin] were used.
Immunohistochemistry
The cell layers (myoblast or myotubes) were fixed with 4%
paraformaldehyde for 20 minutes. Cells were washed three times with
1× PBS, treated with 2 ml ammonium chloride (50 mM) in PBS for
10 minutes and washed three times with PBS/0.2% gelatin and then
incubated with anti-heparan sulfate antibodies (RB4CD12, AO4F12,
AO4BO5) (Jenniskens et al., 2000) for 90 minutes. The following
steps were as described previously (Jenniskens et al., 2003).
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Fig. 3. Effect of RGTA on C2.7 cell differentiation.
(A) C2.7 cells grown at high serum concentrations at day 4,
without treatment (1) or in the presence of 0.5 µg/ml RGTA
(2). C2.7 cells at 24 hours in differentiating medium (0.25%
SVF + 0.25% SC) without treatment (3) or in the presence
of 0.5 µg/ml RGTA (4). Arrows indicate myotubes in the
cultures. (B) Subunits of creatine kinase (CK) and
enzymatic activity at day 4 of C2.7 cell culture. Isoenzyme
analysis was performed after agarose gel electrophoresis
and the percentage of each subunit was calculated as
described in Materials and Methods. CK activity is
expressed as international units per dish. Bar, 100 µm.
Table 1. Primer pairs for real time PCR
Gene Accession no. Sense Antisense Location Size
NDST1 AF074926 CTTGAGCCCTCGGCAGATGC CTACCTCACTGGGCCGTGTC 133-646 514
EXT1 BC004741 GGTCTCTCAGTCCCAGCCAGTG AGTGGCAGGCCAGCGATGTTTG 1654-1780 127
EXT2 BC006597 GCTGTGAAGTGGGCTAGTGTGAGC ATACTTCCACTTGTTCATCTCGTG 1485-1931 447
2OST AF060178 ATTAAGGAGACGGAAACAAGGAG GAAGGGTGGTGACACAGTCAAG 595-1164 570
6OST1 AB024566 ACCAGCAACTCTTTCTATCCC AGCAATACCCACCAGCATC 2186-2720 535
Epimerase AF003927 CCATCTATGACCTCCGGCAC AGTCCCAGCGGGCCAG 1226-1285 59
Heparanase NM152803 TCTGCTGCGGTGTTGAGGA GTAATAGTGATGCCATGTAAGAGA 463-963 501
GAPDH BU504528 ACTCCACTCACGGCAAATTC GACACCAGTAGACTCCACGACA 201-355 155
TFIID D01034 TACTGGAAAGGTCCCCCTCT CTGGCTTGTGTGGGAAAGAT 1156-1367 212
RPII BC042723 TACACCGACTCCACAAACCA TGGACCCAATTAACGATGG 677-852 176
α-Tubulin NM011653 CTTCCCTCTGGCCACTTATG ACTGGATGGTACGCTTGGTC 846-1075 230
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Image analysis 
Confocal microscopy images were acquired using a Zeiss LSM 410
laser-scanning confocal Axiovert 135M inverted microscope. For both
transmission and fluorescence modes, the 488 nm emission ray of an
Ar/Kr laser was used as lighting and excitation source. No emission
filter was used for transmission mode but a 515 nm emission filter was
used for fluorescence mode. Images of fixed cells were obtained with
63× objective with a twofold scanning zoom. Stacks of 40 slices of
0.25 µm thickness were acquired to make a maximum projection on
the z-axis. The final images contain information from the base to the
top of cells. Image treatment procedures (deblurring, improvement of
images by unsharp mask filtering) were developed on a Macintosh
computer G4 using the public domain program Object-Image, which
is an extended version of NIH Image, developed at the U.S. National
Institutes of Health and at the University of Amsterdam.
Evaluation of HS subspecies by ELISA 
The GAG-containing extracts were used for further HS subspecies
determination by ELISA. GAG was grafted on BSA as follows: 100
µl extract containing 1-10 µg/ml of GAG were mixed with 100 µl
BSA (1 mg/ml) diluted in 100 mM phosphate buffer, pH 8.0 and 390
µl phosphate buffer was added. Next, 10 µl of a solution of reducing
agent (NaCNBH3) prepared extemporaneously at 5 mg/ml in
phosphate buffer were added. The mixture was kept at 37°C overnight
under moderate agitation. The BSA-GAG complex was used at 2.5
µg protein/ml to coat ELISA plates overnight at 4°C. The plates were
then rinsed three times with 0.05% PBS-Tween 20. Then 3% BSA in
PBS was added for 1 hour at room temperature. After three washes
in PBS-Tween 20, anti HS diluted at 1:10 in 1% PBS-BSA was added.
Incubation was performed at 37°C for 1.5 hours. After three washes
in PBS-Tween 20, anti c-myc diluted at 1:600 in 1% PBS-BSA was
added and plates were further incubated for 1 hour at room
temperature. After washing, peroxidase-labeled anti IgG were added
(Jackson) and plates were incubated at room temperature for 30
minutes. The plates were again washed three times and TBM kit
reagent (Pierce) was used according to the manufacturer’s
instructions. Absorbance was measured at 450 nm. As a control, CS
or HS from commercial sources were included in the assays.
Statistical analysis
Values are reported as the mean±s.d. Statistical significance was
determined using one-way ANOVA non-parametric test or one-way
ANOVA test followed by Dunnett’s post-test using GraphPad Prism
4 (GraphPad Software, San Diego, CA).
Results
Pattern of GAG content upon C2.7 proliferation and
differentiation
When C2.7 cultures were grown in serum-rich medium, cells
proliferated and then spontaneously formed myotubes after 5
days of culture. Differentiation could be accelerated when
serum-rich medium was replaced with low serum medium
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Fig. 4. Effect of RGTA on total sulfated GAG in C2.7 cellular extracts. Total sulfated GAG determinations were performed using the DMMB
assay in proliferating and differentiating cells grown in the presence or absence of 0.5 µg/ml RGTA. The amounts of GAG were normalized by
the amounts of DNA contained in each sample. Data are the mean±s.d. of duplicates or triplicates from four independent experiments. (A) Total
GAG during proliferation. (B) Cell:medium ratio of total GAG during proliferation. (C) Total GAG during differentiation. (D) Cell:medium
ratio of total GAG during differentiation. *P<0.05; **P<0.005; ***P<0.0005, when total GAG content or cell:medium ratios in RGTA-treated
cells are compared with the respective controls.
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(Figs 2 and 3). Using the DMMB technique, total sulfated
GAG content was measured between days 3 and 6 in C2.7 cells
grown continuously in high serum medium. We refer to cells
grown under these conditions as proliferating cells. In high
serum conditions, total GAG content in cellular extracts
slightly decreased upon withdrawal of proliferation at days 3
and 4 after plating. A moderate increase in total GAG was
noticed at day 5 upon spontaneous differentiation. This
increase was further augmented twofold when cells were
grown in differentiating medium (Fig. 4).
Effect of RGTA on myoblast proliferation and
differentiation
Previous studies have shown that RGTA is a potent stimulating
agent for proliferation and differentiation of rat satellite cells
in primary cultures (Papy-Garcia et al., 2002; Stockholm et al.,
1999). To provide a basis for additional studies we determined
the proliferating and differentiating effects of RGTA on the
C2.7 mouse cell line. As RGTA is a GAG mimetic and some
of its effects were considered similar to a heparin effect, a
heparin control treatment was included in most of the following
experiments. RGTA applied just after plating stimulated
proliferation of C2.7 myoblasts in a dose-dependent manner
(Fig. 2A). The optimal doses for maximal proliferation
stimulation were between 0.5 µg/ml and 1 µg/ml. The decrease
in cell number for high doses of RGTA was partially due to
some cell loss and to cellular differentiation, which was visible.
The kinetics of cell growth in the presence of 0.5 µg/ml RGTA
or 10 µg/ml heparin are shown in Fig. 2B. Compared to
controls, both treatments increased cell growth, but RGTA
appeared more efficient than heparin when considering product
molarities. Whereas 10 µg/ml of heparin represented about 670
nM, the efficient concentration of RGTA was about 6 nM
corresponding to 0.5 µg/ml. Between days 4 and 5, cell growth
was stopped and cultures began to differentiate spontaneously
under our culture conditions. RGTA induces precocious
differentiation of cells in high serum medium (Fig. 3A1,A2).
It also increased differentiation of cells that were shifted to low
serum medium (Fig. 3A3,A4). Within 24 hours after medium
shift from high to low serum, numerous myotubes were seen
in RGTA-treated cultures (Fig. 3A4) whereas myotubes were
almost absent in control cultures (Fig. 3A3). The increased
differentiation in the presence of RGTA was also indicated by
an increase in CK activity and an increase in the proportion of
the muscular isoform (M) of this enzyme (Fig. 3B). These
different results showed that RGTA increased C2.7 growth and
also stimulated their differentiation. We have chosen to focus
our study essentially on the effect of RGTA at the myoblast to
myotube transition, i.e. between day 3 and day 6 after plating,
using the RGTA concentration of 0.5 µg/ml that was effective
on both processes.
RGTA increased GAG content upon proliferation and
differentiation of C2.7
In proliferating cells, RGTA treatment significantly increased
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the amount of total sulfated GAGs between days 4 and 5
compared to controls (Fig. 4A). Whereas the cell-to-medium
ratio of GAGs slightly increased from 1:1 to 2:1 under control
conditions, RGTA treatment further increased the amount of
GAGs in the cellular compartment compared to medium (Fig.
4B).
We also studied GAG changes in cultures in which
differentiation was stimulated by a shift to a low serum
medium (referred to as differentiating medium). In this
medium, total GAG amount increased about twofold in
controls, RGTA further increased this total GAG amount as
showed in Fig. 4C. The cell-to-medium GAG ratio slightly
decreased in control cultures but remained high in RGTA-
treated cultures (Fig. 4D).
Sulfation rate of total GAG was not altered by RGTA
The technique used to assay total sulfated GAG content in cell
extracts was based on the affinity of sulfated GAGs to the
cationic DMMB dye. In order to check if RGTA increased
overall GAGs, and not specifically sulfated GAGs, we performed
another GAG determination using HPLC chromatography of
GAG molecules tagged with a fluorescent chromophore
(anthranilic acid). This method gives a signal directly
proportional to the number of GAG molecules. It allowed the
quantification of total GAGs, including unsulfated species such
as hyaluronic acid. In these experiments, results have shown that
RGTA or heparin increased the total amount of GAGs compared
to controls. Heparin was always less efficient than RGTA in
increasing total GAG content (not shown). This RGTA-induced
increase measured in proliferating cells (Fig. 5A) or in
differentiating cells (Fig. 5B) by the anthranilic acid tag
technique was at similar levels to the increases measured using
the DMMB assay (Fig. 4). This suggested that RGTA did not
change the degree of sulfation of the GAGs. As arylsulfatase
might be involved in changes of the sulfation rates of GAG, we
also measured the activities of arylsulfatase A and B in control
and RGTA-treated cells during differentiation (Fig. 6). Although
arylsulfatase A specific activity did not significantly change in
differentiating cultures (Fig. 6A), arylsulfatase B decreased in
controls about fourfold over the course of differentiation. RGTA
treatment of cultures did not significantly alter the activity of
either sulfatase, although it seemed to slow down the decrease
of arylsulfatase B in differentiating cells.
GAG metabolic enzymes during myogenic differentiation
In order to analyze the possible effect of RGTA on GAG
metabolism, we determined the expression of enzymes
involved in HS biosynthesis and expression of heparanase
using real-time PCR in C2.7 cells under control conditions and
in RGTA-treated cultures. In control cultures, the mRNA levels
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Fig. 7. Analysis of enzymes involved in GAG
metabolism by real-time PCR. Real-time PCR of EXT1
and 2, NDST1, epimerase, 2OST and 6OST1 as well as
heparanase was performed with RNA extracts from
differentiating control and RGTA-treated C2.7 cells.
Values were normalized using the following reference
genes: glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), RNA polymerase II (RPII), TATA-Box
binding protein (TBP) and α-tubulin. Each value is the
mean±s.e. of measurements performed on three
independent cultures.
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of most of the enzymes involved in HS synthesis, namely
EXT1 and -2, NDST1, epimerase, 2OST and 6OST1 did not
significantly change during the differentiation process. In the
presence of RGTA, levels of the mRNAs of the enzymes
involved in HS synthesis were always lower than those of
controls. However, these differences were not statistically
significant.
We also measured the expression of heparanase involved in
HS degradation at the mRNA level (Fig. 7). Interestingly, the
heparanase mRNA level decreased almost to zero in control
cultures within the first 24 hours in differentiating medium.
RGTA did not significantly change this pattern.
RGTA altered GAG species balance during the
myogenic process
As RGTA increased the overall amounts of GAG produced by
cells, we analyzed GAG composition when cells changed from
the proliferating to the differentiating stages. In control
cultures, CS was proportionally more important than HS
during proliferation. HS increased progressively upon
differentiation (not shown). In proliferating cells, RGTA
increased both HS and CS contents two- to threefold when
cells were post-mitotic (days 4-5; Fig. 8A). In differentiating
medium, RGTA specifically increased the HS amount two- to
threefold over control levels, whereas CS was not significantly
altered (Fig. 8B).
HS sub-species and localization in differentiating
myoblasts
It has been demonstrated that HS GAG belongs to a family of
molecules whose composition in the cell environment changes
during biological processes (Jenniskens et al., 2000). Using
three anti-HS antibodies that recognize different HS sub-
domains, we tested GAG composition with an ELISA assay
(Fig. 9). The three antigens were not equally represented in cell
extracts: AO4BO5 epitope seemed to be more abundant than
the others. During the differentiation process, the amount of
HS epitopes did not change significantly in control cultures.
Interestingly, the presence of RGTA slightly modified the HS
sub-species composition. Reactivity to AO4F12 antibody was
Journal of Cell Science 118 (1)
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C2.7 cells. GAG samples were prepared from differentiating controls
and RGTA-treated cells of one representative culture. They were
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mean of duplicate measurements.
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clearly increased 36 hours after medium shift, whereas the
responses to the other antibodies were only slightly enhanced
compared to control levels.
Although RGTA did not seem to alter the localization
of the different HS subspecies compared to controls,
immunocytological analyses of these HS sub-domains revealed
subtle differences in their localization in myoblasts (Fig. 10).
In differentiated cultures, HS antibodies labelled a network that
overlaid the cells. This network was even more accentuated in
myotubes than myoblasts (not shown).
In myoblasts, the RB4CD12 antibody principally delineated
a subset at the periphery of cells (Fig. 10A, arrow 1) and
pseudopodia structures (arrow 2). AO4F12 (Fig. 10B) and
AO4BO5 (Fig. 10C-E) antibodies decorated pseudopodia
structures and cell-to-cell contacts. Pseudopodia between two
cells were often labelled with AO4F12 antibody (Fig. 10B,
arrow 1). Membrane close to these cell-to-cell contacts also
appeared strongly labelled (Fig. 10B, arrow 2). AO4BO5
antibody also labelled pseudopodia structures (Fig. 10C,
arrows 1 and 2). An intense fluorescence was also frequently
observed at the contact zone between two adjacent cells (Fig.
10D, arrow). In addition, cytoplasmic bridges formed between
two presumably pre-fusing cells were also labelled (Fig. 10E,
arrows 1 and 2).
Discussion
It is becoming clear that the extracellular environment
regulates cellular functions as complex as myogenic
differentiation. GAGs are a class of molecules generally
associated with core proteins to form proteoglycans and play
important roles in this environment. For instance, defective
heparan sulfate biosynthesis induces neonatal lethality in mice
(Ringvall et al., 2000) and disturbs Ca2+ homeostasis in
myotubes (Jenniskens et al., 2002). However, there is little
available information about GAG species synthesis in the
course of myogenesis. In the present study, using two
methodological approaches for GAG quantification and
analysis, we observed that GAG composition changed in
cultures of C2.7 myoblasts when shifted from proliferation to
differentiation states. These alterations concerned the overall
GAG content, its distribution between medium and cell layer,
and its species. We have shown that GAGs, and more especially
HSs, were increased during the differentiation process. We
analyzed the expression levels of most of the enzymes involved
in HS metabolism. It must be emphasized that expression
patterns of enzymes responsible for HS synthesis were not
significantly altered during myoblast differentiation. In
contrast, the level of heparanase mRNA was strongly reduced.
This reduction of heparanase correlated with the increase in
overall HS in differentiating cells.
The presence of RGTA, a synthetic GAG mimetic, in the cell
environment increased both myoblast proliferation and
differentiation. The optimal dose for enhancing proliferation
was between 0.1 and 1 µg/ml. At these concentrations, a shift
of B to M creatine kinase isoform, taken as a classical sign
of differentiation, was observed whereas the increase in
total creatine kinase activity occurred at higher RGTA
concentrations. Thus, the concentration of 0.5 µg/ml mainly
used here appeared the optimal dose which favoured the whole
Fig. 10. Immunolocalization of HS in C2.7 myoblasts. Localization of HS subspecies was investigated using (A) RB4CD12, (B) AO4F12 and
(C-E) AO4BO5 antibodies and confocal microscopy. Note the differential labelling of HS species either at the periphery of cells (RB4CD12) or
at cell-to-cell contacts with AO4BO5 or AO4F12. These two antibodies labelled cell-to-cell contacts differentially. Areas indicated by arrows
are described in the text. Panel E shows the boxed area in C. Bar, 10 µm.
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process from proliferation to differentiation. Interestingly it
was shown that RGTA emphasized the changes in GAG
amount, composition and localization observed in control
cultures undergoing differentiation. Heparin was always found
to have a lesser effect than RGTA at equivalent concentrations.
The question of how RGTA could alter GAG synthesis and
whether GAG changes are causal or the consequences of
RGTA effect on proliferation and differentiation remain open.
Cells are influenced by an environment composed of GAG-
containing entities. The presence of RGTA, by itself, modifies
this environment and thus might modify cell behavior. We
believe that the changes brought by the presence of RGTA are
the starting event in the process. RGTA could act first
extracellularly, as do natural GAGs such as HS, by increasing
bioavailability of growth factors and by potentiating growth
factor-mediated proliferation and differentiation. Interestingly,
we have observed, using the same RGTA labeled with FITC,
that this molecule remains for several hours in the cellular
environment of myoblasts as a dense network (I.M.,
unpublished). From this location, RGTA could mediate growth
and also induce phenotypic changes in cells indirectly via
growth factor modulation. We have previously shown that
RGTA stimulates proliferation of satellite cells in primary
cultures and that this effect was partially caused by FGF2
potentiation (Papy-Garcia et al., 2002). RGTA was also shown
to partially substitute for hypo-sulfated GAG in chlorate-
treated cultures and to mediate the FGF2 growth response
(Papy-Garcia et al., 2002). This result could be related to the
observations that chlorate-induced reduction of sulfation of HS
chains of the perlecan proteoglycan in C2C12 myoblasts
diminished their differentiation capacity (Villar et al., 1999).
Stimulation of proliferation has been shown to correlate with
an increase in matrix protein (Porcionatto et al., 1998) and
HSPG secretions in endothelial cells (Weiss and Randour,
2002). Conversely, changes in HS sulfation might alter HBGF
synthesis and intracellular processing. This has been
demonstrated with FGF2 (Sperinde and Nugent, 1998).
The novel findings of the present study were that GAG
mimetics stimulated myogenesis, along with changes in the
natural GAG composition and that RGTA more particularly
increased HS levels. It has long been known that TGFβ activity
is regulated by proteoglycans present in the ECM, and in turn
regulates synthesis of ECM components (Rapraeger, 1989;
Dubaybo and Thet, 1990; Ogawa et al., 1990; Rapraeger et al.,
1991; Anastassiades et al., 1996; Nishikawa et al., 2000).
Similarly, growth factors, including FGF, have been shown to
alter HS composition of smooth muscle cells (Emoto et al.,
1998; Li et al., 2002). We hypothesize that RGTA indirectly
modulates GAG patterns through FGF or TGFβ as it has been
shown to protect these growth factors from proteolysis
(Meddahi et al., 1996).
A possible effect of RGTA on the expression of enzymes
involved in synthesis of GAG was also investigated. The
mRNA of the studied enzymes did not change significantly
during differentiation, and RGTA did not significantly alter the
expression of these enzymes. These results suggest that
changes at the transcriptional level might not be relevant for
studying regulation of the enzymes involved in HS metabolism.
Interestingly, the mRNA of these enzymes all have long 5′
untranslated region (5′-UTR) sequences involved in
translational regulation (Grobe and Esko, 2002). This suggests
a sophisticated regulation at translational levels of regulating
factors that have the property of stimulating synthesis of HS
and molecules that would bind to it. RGTA could interfere with
this regulation.
It should be emphasized that heparanase was the only
enzyme that was significantly altered in differentiating cultures
whatever the treatment. We have also shown that RGTA did
not modify heparanase mRNA expression. This finding does
not preclude an effect at the protein level. An interesting issue
that we are currently exploring is that RGTA may alter
heparanase activity (A. Meddahi et al., unpublished). Such a
hypothesis is supported by studies showing that heparin was
able to reduce the activity of this enzyme in CHO cells
(Tumova and Bame, 1997) and/or may cause a reduced
intracellular degradation of HS through inhibition of
endogenous heparanase as in smooth muscle cells (Potter-
Perigo and Wight, 1996). RGTA was observed to enter into
cells in vesicles where it remains for at least 24 hours (I.M.,
unpublished). We cannot rule out the fact that RGTA may
further modify phenotypic cells from intracellular stores
through an unknown mechanism and alter expression or
activity of the enzymes involved in GAG metabolism.
The complexity of the system is further emphasized by the
fact that levels of the various HS sub-species as revealed by
specific antibodies were all different in RGTA and control
culture conditions. We have shown that HS antibodies detect
different amounts of HS sub-species in differentiating cells
stimulated by RGTA. These HS antibodies, recognizing
different epitopes, differentially decorated the cells. This
suggests sophisticated changes in HS synthesis during
myogenesis. RGTA could participate in these regulations by
discretely modulating the different sets of enzymes involved in
HS synthesis.
Taken together, the present results, showing effects of RGTA
on myoblast growth and differentiation with alteration of GAG
composition, give an important insight into the myogenesis
process, especially as it occurs in a pathological situation such
as skeletal muscle dystrophy or in muscle repair.
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